North America Marine Biotechnology Market Size, Share, and Trends 2025 to 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on North America Marine Biotechnology Market 

5.1. COVID-19 Landscape: North America Marine Biotechnology Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. North America Marine Biotechnology Market, By Source

8.1. North America Marine Biotechnology Market Revenue and Volume, by Source

8.1.1 Corals and sponges

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Algae

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Marine Viruses

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Marine Fungi

8.1.4.1. Market Revenue and Volume Forecast

8.1.5. Others

8.1.5.1. Market Revenue and Volume Forecast

Chapter 9. North America Marine Biotechnology Market, By Application

9.1. North America Marine Biotechnology Market Revenue and Volume, by Application

9.1.1. Aquaculture & Fishery

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Medicine

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Environment

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Biofuels

9.1.4.1. Market Revenue and Volume Forecast

9.1.5. Others

9.1.5.1. Market Revenue and Volume Forecast

Chapter 10. North America Marine Biotechnology Market, By End User

10.1. North America Marine Biotechnology Market Revenue and Volume, by End User

10.1.1. Medical & Pharmaceutical

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Food Industry

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Cosmetics Industry

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Chemical Industry

10.1.4.1. Market Revenue and Volume Forecast

10.1.5. Others

10.1.5.1. Market Revenue and Volume Forecast

Chapter 11. North America Marine Biotechnology Market, and Trend Forecast

11.1. U.S.

11.1.1. Market Revenue and Volume Forecast, by Device Type

11.1.2. Market Revenue and Volume Forecast, by Display Type

11.1.3. Market Revenue and Volume Forecast, by Size

11.1.4. Market Revenue and Volume Forecast, by Display Technology

11.1.5. Market Revenue and Volume Forecast, by End-user

11.1.6.1. Rest of North America

11.1.6.2. Market Revenue and Volume Forecast, by Device Type

11.1.6.3. Market Revenue and Volume Forecast, by Display Type

11.1.6.4. Market Revenue and Volume Forecast, by Size

11.1.6.5. Market Revenue and Volume Forecast, by Display Technology

11.1.6.6. Market Revenue and Volume Forecast, by End-user

Chapter 12. Company Profiles

12.1. Abbott

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Aker Biomarine    

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Biolume Inc

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Cp Kelco

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Cyanotech Corporation

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. FMC Geomarine Biotech

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Lonza Group Ltd.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. FMC Health And Nutrition

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Nutrex Hawaii Incorporated

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Phyco Biotech Sas

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms